BTN1A1, a member of the butyrophilin family , represents an intriguing therapeutic target for diverse immune disorders. The ICT-01-N297A immunoglobin , specifically designed to bind BTN1A1, offers a distinct https://www.targetmol.com/compound/ict_01_n297a